Pfizer is expanding its Chesterfield campus with the construction of a $60 million addition to support vaccine research and development. Providing leading-edge labs, offices, and support spaces, the three-story, 37,000-sf project will adjoin an existing 261,000-sf facility that opened in 2019. A two-story bridge with a covered plaza will link the completed structure to the rest of the 31-acre site.
Pfizer is also investing $470 million to expand and renovate its campus in Pearl River, N.Y. The project includes the construction of a 260,000-sf R&D building offering 55,000 sf of lab space for the creation of next-generation mRNA vaccines. Completion is expected in early 2026. Furthermore, the existing BSL-3 lab on the site will be doubled in size at a cost of $20 million.
